English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIrvine, Calif., Oct. 3, 2024 — With an initial three-year, $33 million grant from the National Institute of Allergy and Infectious Diseases, the University of California, Irvine will lead a multi-institutional drive to create new vaccines as part of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness Network (ReVAMPP).
Tag: physiology & biophysics
UCI professor wins prestigious Robert Koch Prize for groundbreaking research
Irvine, Calif., April 27, 2022 – Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of two scholars to win the prestigious 2022 Robert Koch Prize for fundamental contributions to the transfer of nucleic acids into cells. This pioneering technology for treating infectious diseases played a crucial role in developing the messenger RNA COVID-19 vaccines.
UCI professor wins Spain’s prestigious Princess of Asturias award for scientific research
Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.